Altered platelet cytoskeletal organization and interaction with glycoprotein llb/llla as possible risk factor for thrombotic events in pulmonary hypertension (1998)
- Authors:
- Autor USP: BYDLOWSKI, SERGIO PAULO - FM
- Unidade: FM
- Assunto: CARDIOPATIAS
- Language: Inglês
- Imprenta:
- Source:
- Título: European Heart Journal
- Volume/Número/Paginação/Ano: v. 19, supl, p. 160, res. P1003, 1998
- Conference titles: Congress of the European Society of Cardiology
-
ABNT
MAEDA, N. Y. e BYDLOWSKI, Sérgio Paulo e LOPES, A. A. B. Altered platelet cytoskeletal organization and interaction with glycoprotein llb/llla as possible risk factor for thrombotic events in pulmonary hypertension. European Heart Journal. Vienna: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 11 jan. 2026. , 1998 -
APA
Maeda, N. Y., Bydlowski, S. P., & Lopes, A. A. B. (1998). Altered platelet cytoskeletal organization and interaction with glycoprotein llb/llla as possible risk factor for thrombotic events in pulmonary hypertension. European Heart Journal. Vienna: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Maeda NY, Bydlowski SP, Lopes AAB. Altered platelet cytoskeletal organization and interaction with glycoprotein llb/llla as possible risk factor for thrombotic events in pulmonary hypertension. European Heart Journal. 1998 ; 19 160.[citado 2026 jan. 11 ] -
Vancouver
Maeda NY, Bydlowski SP, Lopes AAB. Altered platelet cytoskeletal organization and interaction with glycoprotein llb/llla as possible risk factor for thrombotic events in pulmonary hypertension. European Heart Journal. 1998 ; 19 160.[citado 2026 jan. 11 ] - Gametic phase disequilibrium between the syntenic multiallelic HTG4 and HMS3 markers widely used for parentage testing in Thoroughbred horses
- The effect of sildenafil in the multimeric composition of plasma von Willebrand factor in pulmonary hypertension: preliminary study
- Comment on: Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years
- Incidence of heparin-induced thrombocytopenia type II and relationship with anti-heparin/PF4 antibody
- Flow-dependent Cardiac Dysfunction and Pressure-dependent Endothelial Activation in Patients With Atrial Septal Defect
- Age-dependent likelihood o In Situ thrombosis in secondary pulmonary hypertension
- Detection of lung resistance-related protein (LRP) expression by RT-PCR in dogs with multicentric lymphoma
- Frequency of the mutations factor V leiden and prothrombin G20210A in patients with diagnosis of heparin induced thrombocytopenia
- Plasma von willebrand factor antigen as an independent risk factor for death in pulmonary arterial hypertension associated with congenital heart disease
- Frequency of human platelet antigens (HPA) 1 to 13 in healthy population
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
